GT199900197A - Formulaciones antiparasitarias. - Google Patents

Formulaciones antiparasitarias.

Info

Publication number
GT199900197A
GT199900197A GT199900197A GT199900197A GT199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A GT 199900197 A GT199900197 A GT 199900197A
Authority
GT
Guatemala
Prior art keywords
formulations
antiparasitary
persons
endoparasites
milbemicines
Prior art date
Application number
GT199900197A
Other languages
English (en)
Inventor
Timothy Michael Lukas
Stephen Richard Wicks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199900197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199900197A publication Critical patent/GT199900197A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A FORMULACIONES ANTIPARASITARIAS Y, EN PARTICULAR, A FORMULACIONES ANTIPARASITARIAS QUE CONTIENEN AVERMECTINAS O MILBEMICINAS, INCLUYENDO DERIVADOS DE LAS MISMAS, QUE SON ADECUADAS PARA SU APLICACION TOPICA EN MAMIFEROS, PERSONAS Y ANIMALES DOMESTICOS COMO PERROS O GATOS INCLUIDOS, Y QUE SON UTILES EN EL TRATAMIENTO DE TRASTORNOS CAUSADOS POR ENDOPARASITOS O ECTOPARASITOS. SON DE ESPECIAL INTERES LAS FORMULACIONES DE SUBSTANCIAS ACTIVAS CONTRA PULGAS Y/O FILARIAS. DICHA FORMULACION ANTIPARASITARIA CONTIENE: (A) UN 0.150% P/V DE UNA AVERMECTINA O DE UNA MILBEMICINA QUE PRESENTA ACTIVIDAD CONTRA ENDOPARASITOS Y ECTOPARASITOS; (B) UN 150% V/V DE UN ETER MONOALQUILICO (C14) DE UN DIALQUILEN (C24) GLICOL; (C) UN ANTIOXIDANTE OPCIONAL; Y OPCIONALMENTE (D) UN DISOLVENTE VOLATIL Q. S. V/V, TOLERABLE POR LA PIEL.
GT199900197A 1998-11-19 1999-11-17 Formulaciones antiparasitarias. GT199900197A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825402.2A GB9825402D0 (en) 1998-11-19 1998-11-19 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
GT199900197A true GT199900197A (es) 2001-05-10

Family

ID=10842728

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900197A GT199900197A (es) 1998-11-19 1999-11-17 Formulaciones antiparasitarias.

Country Status (43)

Country Link
US (1) US6797701B2 (es)
EP (2) EP1130966B2 (es)
JP (1) JP3507799B2 (es)
KR (1) KR100458406B1 (es)
CN (1) CN1147232C (es)
AP (1) AP1210A (es)
AR (1) AR023062A1 (es)
AT (2) ATE288201T1 (es)
BG (1) BG65440B1 (es)
BR (1) BR9915458B1 (es)
CA (1) CA2351730C (es)
CO (1) CO5150175A1 (es)
CY (1) CY1111955T1 (es)
CZ (1) CZ304345B6 (es)
DE (2) DE69942465D1 (es)
DK (2) DK1130966T4 (es)
DZ (1) DZ2945A1 (es)
EA (1) EA003959B1 (es)
ES (2) ES2344505T3 (es)
GB (1) GB9825402D0 (es)
GT (1) GT199900197A (es)
HK (1) HK1040593B (es)
HR (1) HRP20010368B1 (es)
HU (1) HU229493B1 (es)
ID (1) ID28698A (es)
IL (3) IL142104A0 (es)
IS (1) IS5907A (es)
MA (1) MA25029A1 (es)
NO (1) NO20012389D0 (es)
NZ (2) NZ537110A (es)
OA (1) OA11678A (es)
PA (1) PA8485501A1 (es)
PE (1) PE20001319A1 (es)
PL (1) PL204763B1 (es)
PT (2) PT1130966E (es)
SI (2) SI1130966T2 (es)
SK (1) SK287540B6 (es)
TN (1) TNSN99213A1 (es)
TW (1) TW526045B (es)
UY (1) UY25806A1 (es)
WO (1) WO2000030449A1 (es)
YU (1) YU23401A (es)
ZA (1) ZA997174B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
KR20040045440A (ko) 2001-09-17 2004-06-01 일라이 릴리 앤드 캄파니 농약 배합물
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
IES20070395A2 (en) * 2006-12-05 2008-06-11 Michael Hilary Burke A process for the preparation of a stable anhydrous anthelmintic formulation
BRPI1008822B1 (pt) * 2009-02-16 2019-04-09 Zoetis Services Llc Composição veterinária antiparasitária e uso da mesma
EP2416663A2 (en) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasiticidal formulation
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) * 2010-06-17 2012-03-13 Rotam Agrochem International Company Ltd Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
EP3682887A1 (en) * 2010-07-30 2020-07-22 Ceva Sante Animale Compositions comprising ivermectin for treating heartworm infestation
US8901090B2 (en) 2010-10-20 2014-12-02 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
IT1403631B1 (it) * 2011-01-14 2013-10-31 Gsi Geosyntec Invest B V Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) * 2011-03-18 2011-07-29 "Ендектовет" Еоод Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) * 2011-08-25 2013-08-13 Eurofarma Lab Ltda composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
WO2013057222A2 (en) 2011-10-18 2013-04-25 Institut National De La Recherche Agronomique Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
CA2857958C (en) 2011-12-02 2020-08-25 Merial Limited Long-acting injectable moxidectin formulations and moxidectin crystal forms
CN109673653A (zh) * 2012-04-04 2019-04-26 先正达参股股份有限公司 杀有害生物剂组合物
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
WO2014189837A1 (en) * 2013-05-20 2014-11-27 Zoetis Llc Long-acting spiro-isoxazoline antiparasitic compositions
EP3595441B1 (en) 2017-03-17 2023-08-02 KRKA, d.d., Novo mesto Stable topical veterinary composition
WO2019101961A1 (en) * 2017-11-23 2019-05-31 Ceva Sante Animale Composition containing moxidectin for treating parasites infestations
IL275339B2 (en) 2017-12-15 2024-03-01 Tarsus Pharmaceuticals Inc Parasitic formulations containing isoxazoline and methods for treating blepharitis

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (es) * 1972-06-08 1974-02-08
US3839234A (en) 1973-01-26 1974-10-01 C Roscoe Multi-purpose cleaning concentrate
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
DK165119C (da) * 1984-06-05 1993-03-01 American Cyanamid Co Antibiotiske forbindelser betegnet ll-f28249alfa, beta, gamma, delta, epsilon, zeta, eta, theta, iota, kappa, my og ny og pharmaceutisk or pharmakologisk acceptable salte deraf samt fremgangsmaade til deres fremstilling
EP0397292B1 (fr) 1985-01-22 1993-04-21 Saint-Gobain Vitrage International Procédé pour la formation d'une couche mince d'oxydes métalliques sur un substrat, notamment en verre, et son utilisation comme vitrage
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de) 1985-12-20 1987-07-02 Autotyp Sa Schneekette fuer fahrzeugraeder
LU86393A1 (fr) 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
JP2587241B2 (ja) * 1986-07-24 1997-03-05 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物、その製法及びそれを含む医薬組成物
EP0284176B1 (en) * 1987-01-23 1993-08-25 Pfizer Inc. Process for production of avermectins and cultures therefor
DE3727648A1 (de) † 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8807280D0 (en) * 1988-03-26 1988-04-27 Pfizer Ltd Antiparasitic agents
FR2630576B1 (fr) * 1988-04-26 1990-08-17 Realisations Nucleaires Et Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
US4973468A (en) † 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
WO1991013545A1 (en) † 1990-03-05 1991-09-19 Coopers Animal Health, Inc. Parasiticidal composition and methods for its making and use
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5411737A (en) † 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
JP3966479B2 (ja) * 1993-04-16 2007-08-29 日本テキサス・インスツルメンツ株式会社 ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
ES2202324T3 (es) * 1993-05-10 2004-04-01 MERCK & CO., INC. Formulaciones de vertido que contienen material polimerico, glicoles y gliceridos.
TW327125B (en) * 1994-02-07 1998-02-21 Merck & Co Inc Composition and method for protecting against pine exhausted
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
DE19520275A1 (de) † 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
TW362952B (en) 1996-01-30 1999-07-01 Takeda Chemical Industries Ltd Arylpyrazole insecticides
DE19612644A1 (de) † 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
FI107528B (fi) 1998-12-23 2001-08-31 Kemira Chemicals Oy Menetelmä muurahaishapon valmistamiseksi

Also Published As

Publication number Publication date
HUP0104235A3 (en) 2004-03-01
DE69942465D1 (de) 2010-07-15
YU23401A (sh) 2005-06-10
ZA997174B (en) 2001-05-18
EP1130966B2 (en) 2009-05-27
IL142104A0 (en) 2002-03-10
EP1522219A1 (en) 2005-04-13
SI1130966T2 (sl) 2009-08-31
BR9915458B1 (pt) 2011-04-19
AR023062A1 (es) 2002-09-04
PE20001319A1 (es) 2000-12-02
DE69923583T3 (de) 2009-12-24
BG65440B1 (bg) 2008-08-29
JP2002530302A (ja) 2002-09-17
AP9901697A0 (en) 1999-12-31
AP1210A (en) 2003-09-30
WO2000030449A1 (en) 2000-06-02
KR20010080505A (ko) 2001-08-22
DK1522219T3 (da) 2010-08-16
BR9915458A (pt) 2001-07-17
EP1130966A1 (en) 2001-09-12
ES2237213T3 (es) 2009-08-19
SI1522219T1 (sl) 2010-09-30
TNSN99213A1 (fr) 2005-11-10
AU757892B2 (en) 2003-03-13
NZ510678A (en) 2003-08-29
EA003959B1 (ru) 2003-10-30
HRP20010368B1 (en) 2004-06-30
JP3507799B2 (ja) 2004-03-15
HRP20010368A2 (en) 2002-06-30
PA8485501A1 (es) 2000-09-29
EA200100458A1 (ru) 2001-10-22
PL348638A1 (en) 2002-06-03
CZ20011734A3 (cs) 2001-12-12
ES2344505T3 (es) 2010-08-30
PT1522219E (pt) 2010-07-19
DZ2945A1 (fr) 2004-03-15
US6797701B2 (en) 2004-09-28
MA25029A1 (fr) 2000-07-01
EP1522219B1 (en) 2010-06-02
HU229493B1 (en) 2014-01-28
IL173567A0 (en) 2006-07-05
CA2351730C (en) 2006-12-05
OA11678A (en) 2005-01-12
SK287540B6 (sk) 2011-01-04
KR100458406B1 (ko) 2004-11-26
DK1130966T3 (da) 2005-05-09
CO5150175A1 (es) 2002-04-29
TW526045B (en) 2003-04-01
NO20012389L (no) 2001-05-15
GB9825402D0 (en) 1999-01-13
HK1040593A1 (en) 2002-06-21
CN1147232C (zh) 2004-04-28
ATE288201T1 (de) 2005-02-15
HUP0104235A2 (hu) 2002-03-28
PT1130966E (pt) 2005-04-29
DK1130966T4 (da) 2009-07-20
PL204763B1 (pl) 2010-02-26
BG105601A (en) 2002-01-31
NZ537110A (en) 2006-04-28
ID28698A (id) 2001-06-28
CA2351730A1 (en) 2000-06-02
SI1130966T1 (en) 2005-06-30
ATE469550T1 (de) 2010-06-15
AU5995999A (en) 2000-06-13
CN1326318A (zh) 2001-12-12
HK1040593B (zh) 2004-10-08
IL142104A (en) 2006-06-11
DE69923583D1 (de) 2005-03-10
CZ304345B6 (cs) 2014-03-19
EP1130966B1 (en) 2005-02-02
DE69923583T2 (de) 2006-01-12
US20020028780A1 (en) 2002-03-07
CY1111955T1 (el) 2015-11-04
UY25806A1 (es) 2001-08-27
SK6622001A3 (en) 2001-12-03
NO20012389D0 (no) 2001-05-15
IS5907A (is) 2001-03-23

Similar Documents

Publication Publication Date Title
GT199900197A (es) Formulaciones antiparasitarias.
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
BR9903100A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em (-(
BR9907057A (pt) Composição perfumante antimicrobiana, artigo perfumado e utilização da composição.
BR9306564A (pt) Processo para o tratamento da epiderme de um mamífero terrestre sofrendo de uma condição constitída por uma função de barreira epidérmica perturbada
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
SG156624A1 (en) Organo-gel formulations for therapeutic applications
PA8481401A1 (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino
BR0003897A (pt) Aditivo para aumento da resistência à água de formulações cosméticas ou dermatológicas e seus usos
BR9913154A (pt) Composição de musse
AR024516A1 (es) Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica.
ES2181376T3 (es) Composicion cosmetica y/o dermatologica que contiene acido salicilico o un derivado del acido salicilico y su utilizacion.
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
CR6306A (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
ES2136739T3 (es) Copolimeros elastomeros termoplasticos injertados de silicona y composiciones para el cuidado del cabello y de la piel que los contienen.
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
BRPI0608334A2 (pt) uso de uma formulação de clobetasol em lìquido pulverizado para o tratamento de psorìase
AR003984A1 (es) Composiciones antipruriticas, cosmeticas y/o farmaceuticas, procedimiento para su preparacion y empleo de dichas composiciones para la obtencion de unmedicamento.
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
BR9903101A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em